This information was factually accurate on the date it was published. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after its publication dates. For the latest information on Novartis' pipeline, readers should visit the Newsroom and Investors sections of our website.
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
Fighting against meningitidis by finding novel treatments is one of Novartis Vaccines priority.